Frischknecht H R, Siegfried B, Waser P G
Institute of Pharmacology, University of Zürich, Switzerland.
Experientia. 1988 Jun 15;44(6):473-81. doi: 10.1007/BF01958921.
Three animal models, based on genetic differences in endogenous opioid peptides and opioid receptors, are described. Obese mice and rats, whose pituitary opioid content is elevated, may be used to investigate eating disorders. Recombinant inbred strains of mice, which differ in brain opioid receptors and analgesic responsiveness, can be used for study of opioid- and nonopioid-mediated mechanisms of pain inhibition. Individual reactivity to opioids can be examined in C57BL/6 and DBA/2 inbred strains of mice. A model that combines a variety of opioid effects is offered and suggests the existence of a genetically determined dissociation of opioid effects on locomotor activity and pain inhibition. In addition, stimulatory locomotor responses in the C57BL/6 reaction type are linked to a high risk of drug addiction and facilitatory effects on adaptive processes, while high analgesic potency in the DBA/2 reaction type is accompanied by a low proneness to drug abuse and amnesic properties of opioids.
本文描述了三种基于内源性阿片肽和阿片受体基因差异的动物模型。垂体阿片含量升高的肥胖小鼠和大鼠可用于研究饮食失调。脑阿片受体和镇痛反应性不同的重组近交系小鼠可用于研究阿片类和非阿片类介导的疼痛抑制机制。可在C57BL/6和DBA/2近交系小鼠中检测个体对阿片类药物的反应性。本文提供了一个结合多种阿片类药物作用的模型,表明存在基因决定的阿片类药物对运动活动和疼痛抑制作用的解离。此外,C57BL/6反应类型中的刺激性运动反应与药物成瘾的高风险以及对适应性过程的促进作用有关,而DBA/2反应类型中的高镇痛效力则伴随着低药物滥用倾向和阿片类药物的遗忘特性。